124 related articles for article (PubMed ID: 14726626)
1. Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy.
Kawasaki Y; Suzuki J; Sakai N; Etoh S; Murai H; Nozawa R; Suzuki H
Am J Nephrol; 2004; 24(1):147-53. PubMed ID: 14726626
[TBL] [Abstract][Full Text] [Related]
2. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
Shima Y; Nakanishi K; Kamei K; Togawa H; Nozu K; Tanaka R; Sasaki S; Iijima K; Yoshikawa N
Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy.
Kawasaki Y; Hosoya M; Suzuki J; Onishi N; Takahashi A; Isome M; Nozawa R; Suzuki H
Am J Nephrol; 2004; 24(6):576-81. PubMed ID: 15550753
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
Yoshikawa N; Nakanishi K; Ishikura K; Hataya H; Iijima K; Honda M;
Pediatr Nephrol; 2008 May; 23(5):757-63. PubMed ID: 18224343
[TBL] [Abstract][Full Text] [Related]
5. Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation.
Kawasaki Y; Suyama K; Miyazaki K; Kanno S; Ono A; Suzuki Y; Sato M; Hashimoto K; Hosoya M
Nephrology (Carlton); 2014 Jul; 19(7):384-91. PubMed ID: 24646214
[TBL] [Abstract][Full Text] [Related]
6. Use of mizoribine as a rescue drug for steroid-resistant pediatric IgA nephropathy.
Ikezumi Y; Suzuki T; Karasawa T; Kawachi H; Nikolic-Paterson DJ; Uchiyama M
Pediatr Nephrol; 2008 Apr; 23(4):645-50. PubMed ID: 18038158
[TBL] [Abstract][Full Text] [Related]
7. Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.
Kawasaki Y; Maeda R; Ohara S; Suyama K; Hosoya M
Pediatr Int; 2018 Feb; 60(2):162-167. PubMed ID: 29178575
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Shima Y; Nakanishi K; Kaku Y; Ishikura K; Hataya H; Matsuyama T; Honda M; Sako M; Nozu K; Tanaka R; Iijima K; Yoshikawa N;
Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Kamei K; Nakanishi K; Ito S; Saito M; Sako M; Ishikura K; Hataya H; Honda M; Iijima K; Yoshikawa N;
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1301-7. PubMed ID: 21493743
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.
Harmankaya O; Oztürk Y; Baştürk T; Obek A; Kiliçarslan I
Int Urol Nephrol; 2002; 33(1):167-71. PubMed ID: 12090325
[TBL] [Abstract][Full Text] [Related]
11. Mizoribine treatment for childhood IgA nephropathy.
Nagaoka R; Kaneko K; Ohtomo Y; Yamashiro Y
Pediatr Int; 2002 Apr; 44(2):217-23. PubMed ID: 11896890
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of tonsillectomy pulse therapy versus multiple-drug therapy for IgA nephropathy.
Kawasaki Y; Takano K; Suyama K; Isome M; Suzuki H; Sakuma H; Fujiki T; Suzuki H; Hosoya M
Pediatr Nephrol; 2006 Nov; 21(11):1701-6. PubMed ID: 16932894
[TBL] [Abstract][Full Text] [Related]
14. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
Kanno Y; Witt M; Okada H; Nemoto H; Sugahara S; Nakamoto H; Suzuki H
Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of mizoribine combined with losartan in the treatment of IgA nephropathy: a multicenter, randomized, controlled study.
Xie Y; Huang S; Wang L; Miao L; Zhang A; Li Y; Wu X; Wang L; Liu S; Lie C; Chen P; Chen X
Am J Med Sci; 2011 May; 341(5):367-72. PubMed ID: 21293249
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
Kaneko T; Arai M; Ikeda M; Morita M; Watanabe Y; Hirama A; Shimizu A; Tsuruoka S
Int Urol Nephrol; 2015 Nov; 47(11):1823-30. PubMed ID: 26433884
[TBL] [Abstract][Full Text] [Related]
17. A 10-year-old girl with IgA nephropathy who 5 years later developed the characteristic features of Henoch-Schönlein purpura nephritis.
Chishiki M; Kawasaki Y; Kaneko M; Ushijima Y; Ohara S; Abe Y; Suyama K; Hashimoto K; Hosoya M
Fukushima J Med Sci; 2010 Dec; 56(2):157-61. PubMed ID: 21502718
[TBL] [Abstract][Full Text] [Related]
18. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
[TBL] [Abstract][Full Text] [Related]
20. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Yoshikawa N; Honda M; Iijima K; Awazu M; Hattori S; Nakanishi K; Ito H;
Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
